USD 39.24
(4.06%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 776.4 Million USD | -19.24% |
2022 | 961.37 Million USD | 36.93% |
2021 | 702.09 Million USD | 76.02% |
2020 | 398.88 Million USD | 113.31% |
2019 | 186.99 Million USD | 61.49% |
2018 | 115.79 Million USD | 35.18% |
2017 | 85.65 Million USD | 12.02% |
2016 | 76.46 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 638.11 Million USD | -9.21% |
2024 Q2 | 702.84 Million USD | -4.09% |
2024 Q1 | 732.81 Million USD | -5.61% |
2023 Q3 | 810.33 Million USD | -5.1% |
2023 Q4 | 776.4 Million USD | -4.19% |
2023 FY | 776.4 Million USD | -19.24% |
2023 Q1 | 909.97 Million USD | -5.35% |
2023 Q2 | 853.92 Million USD | -6.16% |
2022 Q4 | 961.37 Million USD | -1.87% |
2022 FY | 961.37 Million USD | 36.93% |
2022 Q3 | 979.66 Million USD | -4.11% |
2022 Q2 | 1.02 Billion USD | 29.95% |
2022 Q1 | 786.16 Million USD | 11.97% |
2021 Q3 | 725.29 Million USD | 7.09% |
2021 Q4 | 702.09 Million USD | -3.2% |
2021 Q2 | 677.28 Million USD | -3.18% |
2021 Q1 | 699.57 Million USD | 75.38% |
2021 FY | 702.09 Million USD | 76.02% |
2020 Q2 | 323.87 Million USD | 68.44% |
2020 Q1 | 192.27 Million USD | 2.83% |
2020 FY | 398.88 Million USD | 113.31% |
2020 Q4 | 398.88 Million USD | -2.29% |
2020 Q3 | 408.24 Million USD | 26.05% |
2019 Q4 | 186.99 Million USD | -9.58% |
2019 Q3 | 206.8 Million USD | 47.54% |
2019 Q2 | 140.17 Million USD | -14.77% |
2019 FY | 186.99 Million USD | 61.49% |
2019 Q1 | 164.45 Million USD | 42.03% |
2018 Q4 | 115.79 Million USD | -5.6% |
2018 Q1 | - USD | -100.0% |
2018 FY | 115.79 Million USD | 35.18% |
2018 Q3 | 122.66 Million USD | 0.0% |
2017 Q4 | 85.65 Million USD | 0.0% |
2017 FY | 85.65 Million USD | 12.02% |
2016 FY | 76.46 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 197.4 Million USD | -293.305% |
Biodesix, Inc. | 99.09 Million USD | -683.486% |
bioAffinity Technologies, Inc. | 8.22 Million USD | -9343.509% |
Castle Biosciences, Inc. | 477.81 Million USD | -62.492% |
DarioHealth Corp. | 96.38 Million USD | -705.489% |
Exact Sciences Corporation | 6.47 Billion USD | 88.002% |
IDEXX Laboratories, Inc. | 3.25 Billion USD | 76.183% |
Illumina, Inc. | 10.11 Billion USD | 92.321% |
Intelligent Bio Solutions Inc. | 13.77 Million USD | -5534.739% |
iSpecimen Inc. | 15.81 Million USD | -4807.998% |
Standard BioTools Inc. | 323.06 Million USD | -140.323% |
23andMe Holding Co. | 395.16 Million USD | -96.475% |
Medpace Holdings, Inc. | 1.65 Billion USD | 53.139% |
NeoGenomics, Inc. | 1.68 Billion USD | 53.819% |
Inotiv, Inc. | 856.53 Million USD | 9.355% |
Psychemedics Corporation | 13.27 Million USD | -5750.814% |
Prenetics Global Limited | 254.17 Million USD | -205.465% |
Precipio, Inc. | 18.1 Million USD | -4189.282% |
RadNet, Inc. | 2.88 Billion USD | 73.104% |
Sotera Health Company | 3.13 Billion USD | 75.198% |
Star Equity Holdings, Inc. | 86.97 Million USD | -792.684% |
Exagen Inc. | 56.94 Million USD | -1263.45% |
Natera, Inc. | 1.45 Billion USD | 46.717% |
Aspira Women's Health Inc. | 6.26 Million USD | -12298.643% |
Neogen Corporation | 4.58 Billion USD | 83.063% |
Myriad Genetics, Inc. | 1.19 Billion USD | 35.23% |
ICON Public Limited Company | 16.98 Billion USD | 95.43% |
Bionano Genomics, Inc. | 214.4 Million USD | -262.122% |
CareDx, Inc | 484.61 Million USD | -60.21% |
Check-Cap Ltd. | 25.01 Million USD | -3003.502% |
Guardant Health, Inc. | 1.78 Billion USD | 56.539% |
BioNexus Gene Lab Corp. | 11.39 Million USD | -6710.676% |
Fulgent Genetics, Inc. | 1.27 Billion USD | 39.015% |
Sera Prognostics, Inc. | 95.44 Million USD | -713.49% |
OPKO Health, Inc. | 2.01 Billion USD | 61.406% |
Personalis, Inc. | 225.09 Million USD | -244.916% |
Applied DNA Sciences, Inc. | 13.65 Million USD | -5587.277% |
Star Equity Holdings, Inc. | 86.97 Million USD | -792.684% |
MDxHealth SA | 129.13 Million USD | -501.248% |
Prenetics Global Limited | 254.17 Million USD | -205.465% |
ENDRA Life Sciences Inc. | 6.75 Million USD | -11395.206% |
Mainz Biomed B.V. | 15.4 Million USD | -4938.624% |
Trinity Biotech plc | 59.43 Million USD | -1206.306% |
Neuronetics, Inc. | 115.83 Million USD | -570.289% |
bioAffinity Technologies, Inc. | 8.22 Million USD | -9343.509% |